Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction

•  Introduction •  Transdifferentiation ‐  MSCs differentiate into cardiomyocytes ‐  MSCs differentiate into vascular cells •  Paracrine effects ‐  Endogenous cardiac regeneration induced by paracrine effects ‐  Neovascularization induced by paracrine effects ‐  Anti‐inflammatory effect of MSCs ‐  Anti‐apoptotic effects by MSCs ‐  Cardiac remodelling induced by paracrine effects ‐  Paracrine‐mediated cardiac contractility ‐  Cardiac metabolic modulation by MSCs •  Other potential effects ‐  Cardiac nerve sprouting ‐  Anti‐arrhythmic potential •  Conclusion

• Publication year

  2011

• Venue

  Journal of Cellular and Molecular Medicine

• Publication date

  2011-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1582-4934.2010.01255.xPMID 21199333PMCID 3822616
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• cAMP initiates early phase neuron-like morphology changes and late phase neural differentiation in mesenchymal stem cells

  2011cited by this paper
• Mesenchymal stem cell injection ameliorates the inducibility of ventricular arrhythmias after myocardial infarction in rats.

  2011cited by this paper
• Bone Marrow Mesenchymal Stem Cells Stimulate Cardiac Stem Cell Proliferation and Differentiation

  2010cited by this paper
• Connexin43 promotes survival of mesenchymal stem cells in ischaemic heart

  2010cited by this paper
• Effects of estrogen on diverse stem cells and relevant intracellular mechanisms

  2010influential reference
• Cardiac cell therapy with mesenchymal stem cell induces cardiac nerve sprouting, angiogenesis, and reduced connexin43-positive gap junctions, but concomitant electrical pacing increases connexin43-positive gap junctions in canine heart

  2010cited by this paper
• HO-1 modified mesenchymal stem cells modulate MMPs/TIMPs system and adverse remodeling in infarcted myocardium.

  2010cited by this paper
• TNF RECEPTOR 2, NOT TNF RECEPTOR 1, ENHANCES MESENCHYMAL STEM CELL-MEDIATED CARDIAC PROTECTION FOLLOWING ACUTE ISCHEMIA

  2010cited by this paper
• Improved Function and Myocardial Repair of Infarcted Heart by Intracoronary Injection of Mesenchymal Stem Cell-Derived Growth Factors

  2010cited by this paper
• The Effect of Age on the Efficacy of Human Mesenchymal Stem Cell Transplantation after a Myocardial Infarction

  2010influential reference
• Enhanced mesenchymal cell engraftment by IGF-1 improves left ventricular function in rats undergoing myocardial infarction.

  2010cited by this paper
• Micropatterned three‐dimensional hydrogel system to study human endothelial–mesenchymal stem cell interactions

  2010influential reference
• SDF-1/CXCR4-Mediated Migration of Transplanted Bone Marrow Stromal Cells Toward Areas of Heart Myocardial Infarction Through Activation of PI3K/Akt

  2010cited by this paper
• Intra-myocardial delivery of mesenchymal stem cells ameliorates left ventricular and cardiomyocyte contractile dysfunction following myocardial infarction.

  2010cited by this paper
• Mesenchymal stem cells improve outcomes of cardiopulmonary resuscitation in myocardial infarcted rats.

  2009cited by this paper
• Mesenchymal Stem Cells Promote Matrix Metalloproteinase Secretion by Cardiac Fibroblasts and Reduce Cardiac Ventricular Fibrosis After Myocardial Infarction

  2009cited by this paper
• Stem cell homing and angiomyogenesis in transplanted hearts are enhanced by combined intramyocardial SDF-1alpha delivery and endogenous cytokine signaling.

  2009cited by this paper
• Lipopolysaccharide preconditioning enhances the efficacy of mesenchymal stem cells transplantation in a rat model of acute myocardial infarction

  2009cited by this paper
• Stem Cells Are Not Proarrhythmic: Letting the Genie out of the Bottle

  2009cited by this paper
• Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats.

  2009cited by this paper
• Vascular endothelial growth factor (VEGF) as a key therapeutic trophic factor in bone marrow mesenchymal stem cell-mediated cardiac repair.

  2009cited by this paper
• Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity

  2009cited by this paper
• Improved outcomes of cardiopulmonary resuscitation in rats with myocardial infarction treated with allogenic bone marrow mesenchymal stem cells*

  2009cited by this paper
• Cardiac Progenitor Cells and Biotinylated Insulin-Like Growth Factor-1 Nanofibers Improve Endogenous and Exogenous Myocardial Regeneration After Infarction

  2009cited by this paper
• Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure

  2009cited by this paper
• Early Beneficial Effects of Bone Marrow‐Derived Mesenchymal Stem Cells Overexpressing Akt on Cardiac Metabolism After Myocardial Infarction

  2009cited by this paper
• Stem cells in myocardial infarction: from bench to bedside

  2009cited by this paper
• Hsp20‐Engineered Mesenchymal Stem Cells Are Resistant to Oxidative Stress via Enhanced Activation of Akt and Increased Secretion of Growth Factors

  2009influential reference
• Vascular endothelial growth factor promotes cardiac stem cell migration via the PI3K/Akt pathway.

  2009cited by this paper
• Cell therapy generates a favourable chemokine gradient for stem cell recruitment into the infarcted heart in rabbits

  2009cited by this paper
• Cardiac cell repair therapy: a clinical perspective.

  2009influential reference
• Integrin‐Linked Kinase Is Required in Hypoxic Mesenchymal Stem Cells for Strengthening Cell Adhesion to Ischemic Myocardium

  2009cited by this paper
• Stem Cell Therapy Is Proarrhythmic

  2009cited by this paper
• Insulin-like growth factor 1 improves the efficacy of mesenchymal stem cells transplantation in a rat model of myocardial infarction.

  2008cited by this paper
• Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction.

  2008cited by this paper
• VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma

  2008cited by this paper
• Immuno-inflammatory regulation effect of mesenchymal stem cell transplantation in a rat model of myocardial infarction.

  2008cited by this paper
• Bone Marrow‐Derived Mesenchymal Stromal Cells Express Cardiac‐Specific Markers, Retain the Stromal Phenotype, and Do Not Become Functional Cardiomyocytes In Vitro

  2008cited by this paper
• Forced Myocardin Expression Enhances the Therapeutic Effect of Human Mesenchymal Stem Cells After Transplantation in Ischemic Mouse Hearts

  2008cited by this paper
• Mesenchymal stem cell-derived IL-10 and recovery from infarction: a third pitch for the chord.

  2008cited by this paper
• Impact of Myocardial Infarct Proteins and Oscillating Pressure on the Differentiation of Mesenchymal Stem Cells: Effect of Acute Myocardial Infarction on Stem Cell Differentiation

  2008cited by this paper
• Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis.

  2008cited by this paper
• Cardiogenic Differentiation and Transdifferentiation of Progenitor Cells

  2008cited by this paper
• Formation of Composite Endothelial Cell–Mesenchymal Stem Cell Islets

  2008cited by this paper
• Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy

  2008influential reference
• Effects of combined mesenchymal stem cells and heme oxygenase-1 therapy on cardiac performance.

  2008cited by this paper
• Secreted Frizzled‐Related Protein‐1 Enhances Mesenchymal Stem Cell Function in Angiogenesis and Contributes to Neovessel Maturation

  2008cited by this paper
• Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism.

  2008cited by this paper
• Locally overexpressing hepatocyte growth factor prevents post-ischemic heart failure by inhibition of apoptosis via calcineurin-mediated pathway and angiogenesis.

  2008cited by this paper
• Stromal Cell–Derived Factor-1&agr; Confers Protection Against Myocardial Ischemia/Reperfusion Injury: Role of the Cardiac Stromal Cell–Derived Factor-1&agr;–CXCR4 Axis

  2007cited by this paper
• Mesenchymal Stem Cells Regulate Angiogenesis According to Their Mechanical Environment

  2007cited by this paper
• A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction.

  2007cited by this paper
• Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche

  2007cited by this paper
• Bcl‐2 Engineered MSCs Inhibited Apoptosis and Improved Heart Function

  2007cited by this paper
• Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis.

  2007cited by this paper
• Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair

  2007cited by this paper
• Autologous in vitro expanded mesenchymal stem cell therapy for human old myocardial infarction.

  2007cited by this paper
• Transforming growth factor-beta1 blocks in vitro cardiac myocyte depression induced by tumor necrosis factor-alpha, interleukin-1beta, and human septic shock serum.

  2007influential reference
• Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions

  2007cited by this paper
• Early homing of adult mesenchymal stem cells in normal and infarcted isolated beating hearts

  2007cited by this paper
• Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance.

  2007cited by this paper
• Functional and bioenergetic modulations in the infarct border zone following autologous mesenchymal stem cell transplantation.

  2007cited by this paper
• SDF‐1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction

  2007cited by this paper
• Bone marrow mesenchymal stem cells differentiate into functional cardiac phenotypes by cardiac microenvironment.

  2007cited by this paper
• Intravenously injected mesenchymal stem cells home to viable myocardium after coronary occlusion and preserve systolic function without altering infarct size.

  2007cited by this paper
• Transforming growth factor-&bgr;1 blocks in vitro cardiac myocyte depression induced by tumor necrosis factor-&agr;, interleukin-1&bgr;, and human septic shock serum

  2007cited by this paper
• Stem cell therapy enhances electrical viability in myocardial infarction.

  2007cited by this paper
• Gender differences in injury induced mesenchymal stem cell apoptosis and VEGF, TNF, IL-6 expression: role of the 55 kDa TNF receptor (TNFR1).

  2007cited by this paper
• Evidence supporting paracrine hypothesis for Akt‐modified mesenchymal stem cell‐mediated cardiac protection and functional improvement

  2006cited by this paper
• Controversies in Cardiovascular Medicine

  2006cited by this paper
• Homing and differentiation of mesenchymal stem cells delivered intravenously to ischemic myocardium in vivo: a time-series study

  2006influential reference
• Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction

  2006cited by this paper
• Transplantation of Genetically Engineered Mesenchymal Stem Cells Improves Cardiac Function in Rats with Myocardial Infarction: Benefit of a Novel Nonviral Vector, Cationized Dextran

  2006cited by this paper
• Effects of Myocardial Transplantation of Marrow Mesenchymal Stem Cells Transfected with Vascular Endothelial Growth Factor for the Improvement of Heart Function and Angiogenesis after Myocardial Infarction

  2006cited by this paper
• Human mesenchymal stem cells do not differentiate into cardiomyocytes in a cardiac ischemic xenomodel

  2006cited by this paper
• Estradiol Enhances Recovery After Myocardial Infarction by Augmenting Incorporation of Bone Marrow–Derived Endothelial Progenitor Cells Into Sites of Ischemia-Induced Neovascularization via Endothelial Nitric Oxide Synthase–Mediated Activation of Matrix Metalloproteinase-9

  2006cited by this paper
• Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation.

  2006cited by this paper
• Profound bioenergetic abnormalities in peri-infarct myocardial regions.

  2006cited by this paper
• Proarrhythmic Potential of Mesenchymal Stem Cell Transplantation Revealed in an In Vitro Coculture Model

  2006cited by this paper
• Cell-to-cell contact induces mesenchymal stem cell to differentiate into cardiomyocyte and smooth muscle cell.

  2006influential reference
• Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction.

  2005cited by this paper
• Effects of bone marrow derived mesenchymal stem cells transplantation in acutely infarcting myocardium

  2005cited by this paper
• Regeneration of Infarcted Myocardium by Intramyocardial Implantation of Ex Vivo Transforming Growth Factor-&bgr;–Preprogrammed Bone Marrow Stem Cells

  2005cited by this paper
• Vascular Endothelial Growth Factor–Expressing Mesenchymal Stem Cell Transplantation for the Treatment of Acute Myocardial Infarction

  2005cited by this paper
• Mesenchymal Stem Cells Differentiate into an Endothelial Phenotype, Enhance Vascular Density, and Improve Heart Function in a Canine Chronic Ischemia Model

  2005cited by this paper
• Human mesenchymal stem cells modulate allogeneic immune cell responses.

  2005cited by this paper
• Cardiovascular Disease in the Developing World and Its Cost-Effective Management

  2005cited by this paper
• Effects of mesenchymal stem cell transplantation on extracellular matrix after myocardial infarction in rats

  2005cited by this paper
• Increased heme oxygenase-1 expression in infarcted rat hearts following human bone marrow mesenchymal cell transplantation.

  2005cited by this paper
• Mesenchymal, but not hematopoietic, stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction in mice.

  2005cited by this paper
• Allogeneic Mesenchymal Stem Cell Transplantation in Postinfarcted Rat Myocardium: Short- and Long-Term Effects

  2005cited by this paper
• Cardiac Stem Cells Possess Growth Factor-Receptor Systems That After Activation Regenerate the Infarcted Myocardium, Improving Ventricular Function and Long-Term Survival

  2005cited by this paper
• Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction.

  2004cited by this paper
• Bone Marrow Cells Differentiate in Cardiac Cell Lineages After Infarction Independently of Cell Fusion

  2004cited by this paper
• Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis.

  2004cited by this paper
• Mesenchymal Stem Cells Can Be Differentiated Into Endothelial Cells In Vitro

  2004cited by this paper
• Marrow-Derived Stromal Cells Express Genes Encoding a Broad Spectrum of Arteriogenic Cytokines and Promote In Vitro and In Vivo Arteriogenesis Through Paracrine Mechanisms

  2004influential reference
• Mesenchymal Stem Cell Injection Induces Cardiac Nerve Sprouting and Increased Tenascin Expression in a Swine Model of Myocardial Infarction

  2003cited by this paper
• Polycythemia vera: myths, mechanisms, and management.

  2002cited by this paper
• Bone marrow cells regenerate infarcted myocardium

  2001cited by this paper

• Fetal adnexa-derived allogeneic mesenchymal stem cells for cardiac regeneration: the future trend of cell-based therapy for age-related adverse conditions

  2025cites this paper
• Scientometric analysis of evolution in sex-specific MSC therapy for cardiovascular diseases.

  2025cites this paper
• A unique bioreactor that offers synchronized physiological-like electrical and mechanical stimuli for cardiac tissue engineering

  2025cites this paper
• The Role of the Extracellular Matrix in Inducing Cardiac Cell Regeneration and Differentiation

  2025cites this paper
• Pericardial Administration of Extracellular Vesicles Derived from Bone Marrow Stem Cells Improved Doxorubicin-induced Heart Failure with Mid Range Ejection Fraction (HFmrEF) in Rats.

  2025cites this paper
• Innovative Therapeutic Strategies for Myocardial Infarction Across Various Stages: Non-Coding RNA and Stem Cells

  2024cites this paper
• Innovative hydrogel-based therapies for ischemia-reperfusion injury： bridging the gap between pathophysiology and treatment

  2024cites this paper
• BMSCs-derived Exosome CISH Alleviates Myocardial Infarction by Inactivating the NF-κB Pathway to Stimulate Macrophage M2 Polarization

  2024cites this paper
• Mesenchymal Stem Cell-Derived Exosomes and Their MicroRNAs in Heart Repair and Regeneration

  2023cites this paper
• Bone marrow mesenchymal stromal cell-derived small extracellular vesicles: A novel therapeutic agent in ischemic heart diseases

  2023cites this paper
• Cadmium-Induced Testicular Damage in Rats: Modulatory Role of Stemenhance® Against Oxidative Stress

  2023cites this paper
• Mechanisms and Optimization Strategies of Paracrine Exosomes from Mesenchymal Stem Cells in Ischemic Heart Disease

  2023cites this paper
• Exoskeleton Partial‐Coated Stem Cells for Infarcted Myocardium Restoring

  2023cites this paper
• Exosomes secreted from bone marrow mesenchymal stem cells suppress cardiomyocyte hypertrophy through Hippo-YAP pathway in heart failure

  2023cites this paper
• Substrate topography regulates extracellular matrix component secretion by bone marrow-derived mesenchymal stem cells

  2022cites this paper
• Potential applications of natriuretic peptide system in cardiovascular regenerative medicine

  2022cites this paper
• Microfluidic Potentiometric Cytometry for Size-Selective Micro Dispersion Analysis

  2022cites this paper
• Therapeutic Potential of Mesenchymal Stem Cells versus Omega n − 3 Polyunsaturated Fatty Acids on Gentamicin-Induced Cardiac Degeneration

  2022cites this paper
• Role of Inflammatory Niche and Adult Cardiomyocyte Coculture on Differentiation, Matrix Synthesis, and Secretome Release by Human Bone Marrow Mesenchymal Stem Cells

  2022cites this paper
• The Possible Enhancement Effect of Vitamin E on the Mesenchymal Stem Cell Treatment of Isoproterenol Induced Myocardial Infraction in Male Albino Rats

  2021cites this paper
• Cardiac Cell Therapy for Heart Repair: Should the Cells Be Left Out?

  2021cites this paper
• Therapeutic Application of Perinatal Stem Cells in Cardiovascular Diseases: Current Progress and Future Prospects

  2021cites this paper
• Histological and Immunohistochemical Study of the Possible Therapeutic Effect of Mesenchymal Stem Cells, Their Exosomes and Vitamin E on Experimentally Induced Cardio-Toxicity in Adult Male Albino Rats

  2020cites this paper
• Autologous CXCR4+ Hematopoietic Stem Cells Injected Into the Scar Tissue of Chronic Myocardial Infarction Patients Normalizes Tissue Contractility and Perfusion.

  2020cites this paper
• Histological and immunohistochemical study on the possible therapeutic role of stem cells and curcumin in cyclophosphamide-induced cardiotoxicity in adult male albino rat

  2020cites this paper
• The Role of Angiogenesis-Inducing microRNAs in Vascular Tissue Engineering

  2020cites this paper
• Analysis of mesenchymal stem cell proteomes in situ in the ischemic heart

  2020cites this paper
• miR-19a/19b-loaded exosomes in combination with mesenchymal stem cell transplantation in a preclinical model of myocardial infarction.

  2020cites this paper
• miR-19a/19b improves the therapeutic potential of mesenchymal stem cells in a mouse model of myocardial infarction

  2020cites this paper
• Mesenchymal stem cell-derived exosomes ameliorate cardiomyocyte apoptosis in hypoxic conditions through microRNA144 by targeting the PTEN/AKT pathway

  2020cites this paper
• Allogeneic umbilical cord-derived mesenchymal stem cell transplantation for treating chronic obstructive pulmonary disease: a pilot clinical study

  2020cites this paper
• Nerve Regeneration and Stem Cells

  2019cites this paper
• Transplantation of CRISPRa system engineered IL10-overexpressing bone marrow-derived mesenchymal stem cells for the treatment of myocardial infarction in diabetic mice

  2019cites this paper
• Exosomes derived from pro‐inflammatory bone marrow‐derived mesenchymal stem cells reduce inflammation and myocardial injury via mediating macrophage polarization

  2019cites this paper
• Production of Mesenchymal Stem Cells through Stem Cell Reprogramming

  2019cites this paper
• The impact of mesenchymal stem cells on doxorubicin‐induced testicular toxicity and progeny outcome of male prepubertal rats

  2019cites this paper
• Substantial Overview on Mesenchymal Stem Cell Biological and Physical Properties as an Opportunity in Translational Medicine

  2019cites this paper
• Stem cells for treatment of musculoskeletal conditions orthopedic/sports medicine applications.

  2019cites this paper
• Prevascularized mesenchymal stem cell-sheets increase survival of random skin flaps in a nude mouse model.

  2019cites this paper
• Differential roles of microtubules in the two formation stages of membrane nanotubes between human mesenchymal stem cells and neonatal mouse cardiomyocytes.

  2019cites this paper
• Follistatin-like 1 protects mesenchymal stem cells from hypoxic damage and enhances their therapeutic efficacy in a mouse myocardial infarction model

  2019cites this paper
• Exosomes derived from SDF1‐overexpressing mesenchymal stem cells inhibit ischemic myocardial cell apoptosis and promote cardiac endothelial microvascular regeneration in mice with myocardial infarction

  2019cites this paper
• Ocena potencjału biologicznego mikropęcherzyków z hodowli antygenowo zdefiniowanych komórek macierzystych szpiku kostnego dla celów regeneracji tkanek

  2019cites this paper
• Myocardial Cell Signaling During the Transition to Heart Failure: Cellular Signaling and Therapeutic Approaches.

  2018cites this paper
• Concise Review: Optimized Strategies for Stem Cell‐Based Therapy in Myocardial Repair: Clinical Translatability and Potential Limitation

  2018cites this paper
• Current Strategies to Generate Human Mesenchymal Stem Cells In Vitro

  2018cites this paper
• Effects of different doses of granulocyte colony-stimulating factor mobilization therapy on ischemic cardiomyopathy

  2018cites this paper
• Inhibition of mircoRNA-34a Enhances Survival of Human Bone Marrow Mesenchymal Stromal/Stem Cells Under Oxidative Stress

  2018cites this paper
• Diazoxide effects on proliferation and apoptosis of bone marrow mesenchymal stem cells under hypoxic conditions

  2018cites this paper
• NYHA Stage Stage I Stage II Stage III Stage IV Symptoms None Mild Moderate Severe ACE inhibitors

  2018cites this paper
• Efecto del Medio Condicionado de la Línea Celular H9C2 Tratada con Dehidroepiandrosterona y Expuesta a Daño sobre la Motilidad de Células Troncales Mesenquimales

  2017cites this paper
• Novel stem cell transporter and method for producing same

  2017cites this paper
• Apelin promotes mesenchymal stem cells survival and vascularization under hypoxic-ischemic condition in vitro involving the upregulation of vascular endothelial growth factor.

  2017cites this paper
• Functional Maturation of Engineered Myocardium for Studies of Development and Regeneration

  2017cites this paper
• Nanoparticle-mediated Cell Behavior Modulation for the Treatment of Myocardial Infarction

  2017cites this paper
• MAST CELLS IMPROVE CARDIAC FUNCTION TRANSIENTLY AFTER AN MI AND MODULATE DIFFERENTIATION/PROLIFERATION STAGE OF MESENCHYMAL STEM CELLS THROUGH PDGF

  2017cites this paper
• Keratin mediated attachment of stem cells to augment cardiomyogenic lineage commitment.

  2017cites this paper
• Morphological and functional changes in bone marrow mesenchymal stem cells in rats with heart failure

  2017cites this paper
• Effect of the conditioned medium from H9C2 cell line treated with dehydroepiandrosterone and exposed to damage on the motility of mesenchymal stem cells

  2017cites this paper
• A CLONAL POPULATION OF ALLOGENEIC BONE MARROW FIBROBLASTS INDIRECTLY MITIGATES DAMAGE IN MYOCARDIAL INFARCTION

  2017cites this paper
• A Story About Cardiac Stem Cells

  2017cites this paper
• Digoxin as a cardiac glycosoids induced apoptosis in mesenchymal stem cells: an in Vitro study

  2017cites this paper
• Tracking stem cells with superparamagnetic iron oxide nanoparticles: perspectives and considerations

  2017cites this paper
• Chitosan hydrogel improves mesenchymal stem cell transplant survival and cardiac function following myocardial infarction in rats

  2017cites this paper
• Intramuscular injection of human umbilical cord-derived mesenchymal stem cells improves cardiac function in dilated cardiomyopathy rats

  2017cites this paper
• Valproic acid enhances the neural differentiation of human placenta derived‐mesenchymal stem cells in vitro

  2016cites this paper
• Protocols and Manufacturing for Cell-Based Therapies Mesenchymal Stem Cells and Mononuclear Cells FromCordBlood : CotransplantationProvides aBetter Effect in Treating Myocardial Infarction

  2016cites this paper
• Advances in the Use of Stem Cells in Veterinary Medicine: From Basic Research to Clinical Practice

  2016cites this paper
• Vascular Wall-Resident Multipotent Stem Cells of Mesenchymal Nature within the Process of Vascular Remodeling: Cellular Basis, Clinical Relevance, and Implications for Stem Cell Therapy

  2016cites this paper
• B Cell Lymphoma-2-Modified Bone Marrow-Derived Mesenchymal Stem Cells Transplantation for the Treatment of Diabetes Mellitus-Induced Erectile Dysfunction in a Rat Model

  2016cites this paper
• Therapy with Multipotent Mesenchymal Stromal Cells Protects Lungs from Radiation-Induced Injury and Reduces the Risk of Lung Metastasis

  2016cites this paper
• Mast cells promote proliferation and migration and inhibit differentiation of mesenchymal stem cells through PDGF.

  2016cites this paper
• Evaluation of Multiple Biological Therapies for Ischemic Cardiac Disease

  2016cites this paper
• Mesenchymal Stem Cells and Mononuclear Cells From Cord Blood: Cotransplantation Provides a Better Effect in Treating Myocardial Infarction

  2016cites this paper
• Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010–2015)

  2016cites this paper
• Protection of the muscle stem cell state from premature differentiation

  2016cites this paper
• Identification of mesenchymal stem cell differentiation state using dual-micropore microfluidic impedance flow cytometry

  2016cites this paper
• MicroRNA-Mediated Regulation of Cardiovascular Differentiation and Therapeutic Implications

  2015cites this paper
• TGF-β1 induces apoptosis of bone marrow-derived mesenchymal stem cells via regulation of mitochondrial reactive oxygen species production.

  2015cites this paper
• Rap1-mediated nuclear factor-kappaB (NF-κB) activity regulates the paracrine capacity of mesenchymal stem cells in heart repair following infarction

  2015cites this paper
• Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and osteogenesis in rabbit femoral head osteonecrosis.

  2015cites this paper
• Translational Animal Models for Regenerative Medicine Research

  2015cites this paper
• Peroxisome Proliferator-Activated Receptor Gamma Promotes Mesenchymal Stem Cells to Express Connexin43 via the Inhibition of TGF-β1/Smads Signaling in a Rat Model of Myocardial Infarction

  2015cites this paper
• Effect of Exosomes from Mesenchymal Stem Cells on Angiogenesis

  2015cites this paper
• Synergistic effect of angiotensin II on vascular endothelial growth factor-A-mediated differentiation of bone marrow-derived mesenchymal stem cells into endothelial cells

  2015cites this paper
• Iron oxide nanoparticle-mediated development of cellular gap junction crosstalk to improve mesenchymal stem cells' therapeutic efficacy for myocardial infarction.

  2015cites this paper
• Does selenium improve the stem cell therapeutic effect on isoproterenol-induced myocardial infarction in rats? A histological and immunohistochemical study

  2015cites this paper
• Bone Marrow Therapies for Chronic Heart Disease

  2015cites this paper
• Unique molecular signatures influencing the biological function and fate of post‐natal stem cells isolated from different sources

  2015cites this paper
• Cardiac stem cells transplantation enhances the expression of connexin 43 via the ANG II/AT1R/TGF-beta1 signaling pathway in a rat model of myocardial infarction.

  2015cites this paper
• microRNA-378 promotes mesenchymal stem cell survival and vascularization under hypoxic–ischemic conditions in vitro

  2014cites this paper
• Cytotoxic Effects of Digoxin on Mesenchymal Stem Cells: An in Vitro Study

  2014cites this paper
• Featured Article: Transplantation of mesenchymal stem cells carrying the human receptor activity-modifying protein 1 gene improves cardiac function and inhibits neointimal proliferation in the carotid angioplasty and myocardial infarction rabbit model

  2014cites this paper
• Bone marrow mesenchymal stem cell aspirates from alternative sources: is the knee as good as the iliac crest?

  2014cites this paper
• Autologous bone marrow mononuclear cell therapy improves symptoms in patients with end-stage peripheral arterial disease and reduces inflammation-associated parameters.

  2014cites this paper
• Activated Platelets Interfere with Recruitment of Mesenchymal Stem Cells to Apoptotic Cardiac Cells via High Mobility Group Box 1/Toll-like Receptor 4-mediated Down-regulation of Hepatocyte Growth Factor Receptor MET*

  2014cites this paper
• Human umbilical cord tissue-derived mesenchymal stromal cells attenuate remodeling after myocardial infarction by proangiogenic, antiapoptotic, and endogenous cell-activation mechanisms

  2014cites this paper
• Mesenchymal stem cells enhanced cardiac nerve sprouting via nerve growth factor in a rat model of myocardial infarction.

  2014cites this paper
• Interaction between myofibroblasts and stem cells in the fibrotic heart: balancing between deterioration and regeneration.

  2014cites this paper
• Reversal of Ischemic Cardiomyopathy with Sca-1+ Stem Cells Modified with Multiple Growth Factors

  2014cites this paper